Accepted at 5:35 p.m. May, 02, 2024 by beejumm
Author: beejumm
Related Note: 1522762646364 1
Rationale for change

added extra info for better contrast between management of asymptomatic vs symptomatic CLL

Amboss SA 2024 block 1 question 27 tests what the management of asymptomatic CLL is
There's no card (as far i could tell) in AnKing that mentions/tests this

Source: AMBOSS - https://next.amboss.com/us/review/sI9g0tVKx2/27

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step2_v12::Original_decks::Zanki_Step_2::UW #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::04_Chronic_Lymphocytic_Leukemia #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::02_Chronic_Leukemias_SOAP #AK_Step2_v12::#Resources_by_rotation::IM::uw::#misc_zanki #AK_Step2_v12::#FirstAid::07_Hematology::05_White_Blood_Cell_Disorders::04_Leukemias::Extra #AK_Step1_v12::#Pixorize::02_Immunology::04_B_Cells_&_T_Cells::03_B_Cells-Overview #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Other::Only_Step_2 #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::05_Chronic_Lymphocytic_Leukemia_(CLL) #PANCE::HEME::neoplasms_premalignancies_malignancies #AK_Step2_v12::#UWorld::#UWSA1 #AK_Step2_v12::#AMBOSS #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step2_v12::#AMBOSS::wt0hf3 #AK_Step2_v12::#AMBOSS::Ct0qf3 #AK_Step2_v12::#AMBOSS::7Q04xf #AK_Step2_v12::#UWorld::Step::6884 #AK_Other::#AK_Original_Decks::Step_2::Zanki_Step_2 #AK_Step2_v12::#Subjects::Hematology::03_WBC::02_Leukemia::Chronic_Leukemia::Chronic_Lymphocytic_Leukemia